FINWIRES · TerminalLIVE
FINWIRES

ゴールドクエスト・マイニング社、ドミニカ共和国のロメロ金・銅プロジェクトにおける深度拡張の可能性を報告

By

-- ゴールドクエスト・マイニング(GQC.V)は水曜日、ドミニカ共和国のロメロ鉱床で実施中の探査掘削プログラムの予備的な視覚的結果を発表した。 同社によると、最近掘削されたLTP-182号孔とLTP-183号孔は、ロメロ鉱床の特徴と一致する「有望な」変質帯と鉱化帯を貫通した。これらの鉱化帯は、既存の鉱物資源ブロックモデルの外側に位置している。同社は、これらの結果は、既知の鉱化帯の深度方向および走向方向の両方において、鉱化帯が延長している可能性を裏付けるものだと付け加えた。 両孔の掘削は、既存の掘削リグが掘削深度限界に達したため、一時的に中断されている。同社は現在、より高性能な代替掘削リグを配備中であると述べた。 新しいリグは、LTP-183号孔に投入され、目標深度まで掘削を進めた後、LTP-182号孔の掘削を完了するために移動する予定である。掘削は4月下旬までに再開される見込みである。 同社は、新たに特定されたこれらの鉱床の連続性、形状、品位分布を検証するため、さらなる掘削を計画していると述べた。 同社の株価は、トロント証券取引所ベンチャー市場で直近の取引で0.07ドル高の2.22ドルとなっている。

Price: $2.20, Change: $+0.05, Percent Change: +2.33%

Related Articles

Treasury

Scotiabank Previews This Week's February and Preliminary March GDP for Canada

Canada reports gross domestic product for February and the preliminary estimate for March on Thursday, said Scotiabank.February was initially guided by Statistics Canada to have been tracking a 0.2% month-over-month gain last month. Updated estimates are still in the same ballpark, but investors also get important details on sector drivers, noted the bank.More meaningful may be the flash guidance, with no details, for March GDP, for which there is very little information so far, but a small gain is "feasible," stated Scotiabank.The outcome will further inform Q1 GDP growth tracking on a production/income basis using monthly GDP. It's feasible that growth is tracking close to the Bank of Canada's 1.8% January Monetary Policy Report estimate, but that's on an expenditure basis. The massive over 4% inventory drag on Q4 GDP could reverse as an added upside, pointed out the bank.One key is that consumer spending on goods is tracking a strong rebound in Q1 based on retail sales volumes. It's untrue that the economy isn't exhibiting rate sensitivity, a view that is disproportionately driven by a false understanding of what's keeping condo markets weak in Toronto and Vancouver, added Scotiabank.

$$CXY
Australia

Vicor Insider Sold Shares Worth $2,079,226, According to a Recent SEC Filing

Alvaro Doyle, Vice President and Chief Information Officer, on April 23, 2026, sold 8,000 shares in Vicor (VICR) for $2,079,226. Following the Form 4 filing with the SEC, Doyle has control over a total of 42 common shares of the company, with 42 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/751978/000182673026000002/xslF345X05/primary_doc.xmlPrice: $265.29, Change: $-8.24, Percent Change: -3.01%

$VICR
Australia

BioMarin Seen Building Broader Rare-Disease Platform After Amicus Deal, Morgan Stanley Says

BioMarin Pharmaceutical (BMRN) is emerging as a broader rare-disease platform as its acquisition of Amicus Therapeutics (FOLD) adds two approved medicines and reduces reliance on Voxzogo, Morgan Stanley said Monday in a report.The Amicus deal reshapes BioMarin's outlook by adding Galafold and Pombiliti with Opfolda, products that fit the company's global commercial network, the report said. The therapies are expected to generate more than $1.3 billion in revenue by 2030, Morgan Stanley said.The acquisition is projected to accelerate revenue growth immediately after closing and to be accretive to non-GAAP earnings within 12 months, with "substantial accretion" beginning in 2027, the report said. BioMarin closed its $4.8 billion purchase of Amicus on Monday.Morgan Stanley resumed coverage on BioMarin stock with an overweight rating and a $120 price target.Price: $54.08, Change: $+0.90, Percent Change: +1.68%

$BMRN$FOLD